Clinical trial
A Prospective, Observational Study in Patients With Late-Onset Pompe Disease
NCT00077662 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00077662 |
|---|---|
| Title | A Prospective, Observational Study in Patients With Late-Onset Pompe Disease |
| Official title | A Prospective, Observational Study in Patients With Late-Onset Pompe Disease |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Glycogen Storage Disease Type II |
| Enrollment | 61 |
| Start date | Mar 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Feb 12, 2004 |
| Last update posted | May 5, 2015 |
| Countries | France, Netherlands, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: